Cell line · CVCL_0609
Calu-3
Cancer cell line, Homo sapiens. Lung adenocarcinoma. 122 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. Calu-3. Cell lines, record CVCL_0609. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0609
On this page
Cell line
As Cellosaurus gives it.
- Name
- Calu-3
- Accession
- CVCL_0609
- RRID
- RRID:CVCL_0609
- Synonyms
- CaLu-3, CALU-3, Calu 3, Calu3, CALU3
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 25Y
- Category
- Cancer cell line
- Diseases
- Lung adenocarcinoma (NCIt C3512)
- Derived from
- Pleural effusion (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers122
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Searching for Novel COVID19 Treatments: Towards Covalent TMPRSS2 Inhibitors. | ChemMedChem | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Calu-3 cells as novel efficient cell culture system for Borna disease virus 1 (BoDV-1). | Virus Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Host cell entry and neutralisation sensitivity of H3N2 influenza A virus subclade K. | NPJ Vaccines | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The conserved QTQTX motif in the SARS-CoV-2 spike protein is dispensable for cleavage and lung cell entry of the emerging variant BA.3.2. | J Virol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Hypoxia-inducible Factor 1α-dependent Induction of Alveolar miR-147b and Direct Targeting of Viral RNA in SARS-CoV-2-associated Acute Respiratory Distress Syndrome. | Anesthesiology | 2026 | Its Methods give the RRID and name the line | PubMed | |
| miR-29a and miR-15b Modulate SARS-CoV-2 Beta and Omicron Infection in Human Lung Epithelial Cells. | Int J Mol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Multi-Omics reveals SPP1 + malignant and CXCR4+ TAM crosstalk predicts immunotherapy response in lung adenocarcinoma. | Discov Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Q1020R in the spike proteins of MERS-CoV from Arabian camels confers resistance against soluble human DPP4. | J Virol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| AXL-SHC1 signaling axis mediates adaptive resistance to HER2-targeted tyrosine kinase inhibitors in HER2-aberrant lung and gastric cancers. | NPJ Precis Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting peptidyl-arginine deiminase 4 suppresses SARS-CoV-2 replication and modulates the inflammatory response. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 122
See all 122 papersRelatives5
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | Abcam Calu-3 TMPRSS2 KO | CVCL_B0ZC | Cell lines | |
| Derived from it | Calu-3 2B4 | CVCL_YZ47 | Cell lines | |
| Derived from it | Calu3-GemR | CVCL_EQ19 | Cell lines | |
| Derived from it | EDITGENE Calu-3-CopGFP | CVCL_F6AL | Cell lines | |
| Derived from it | EDITGENE Calu-3-FLUC | CVCL_F5ST | Cell lines |
Cell banks11
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | HTB-55 | ATCC | |
| Abcam | ab275465 | Abcam | |
| AddexBio | C0016001/30 | Cellosaurus | |
| BCRJ | 0264 | BCRJ | |
| CLS | 305032 | CLS | |
| CancerTools | 161906 | CancerTools | |
| EDITGENE | EDC00032 | EDITGENE | |
| IZSLER | BS TCL 103 | Cellosaurus | |
| KCB | KCB 202003YJ | Cellosaurus | |
| KCLB | 30055 | KCLB |
1 to 10 of 11
See all 11 cell banksData dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0609
GET https://conductscience.org/api/cell-lines/v1/CVCL_0609/papers?page=2